Our path starts here
Join us on our journey as we drive scientific research to improve patient treatments for tomorrow.
The Institute’s Cancer Center is one of only seven NCI-designated basic cancer research centers in the nation. We couple fundamental biological research with early translational studies to find new, innovative therapies that restore hope to cancer patients and their families.
Francesca Marassi, Ph.D.
Professor, Cancer Metabolism and Signaling Networks Program
Garth Powis, D. Phil.
Jeanne and Gary Herberger Leadership Chair in Cancer Research
The Center for Metabolic Origins of Disease studies common diseases that have reached pandemic scale including obesity, type 2 diabetes and cardiovascular complications. We have established an exciting environment that promotes multi-disciplinary discovery research toward breakthrough preventive and therapeutic strategies.
Laszlo Nagy, M.D., Ph.D.
Director and Adjunct Professor, Genomic Control of Metabolism Program
Masanobu Komatsu, Ph.D.
Adjunct Associate Professor, Cardiovascular Metabolism Program
The human immune system is made up of a network of cells, tissues and organs that fight off disease. It can also turn against the body causing autoimmune disorders, such as rheumatoid arthritis, lupus, Crohn’s disease and psoriasis. Increasingly, scientists are learning how to help the body’s immune system to combat cancer.
Alex Strongin, Ph.D., D.Sci.
Professor, Bioinformatics and Structural Biology Program
Adam Godzik, Ph.D.
Director and Professor, Bioinformatics and Structural Biology Program
Diseases associated with aging and development are already a leading cause of death and disability, and their prevalence is rising fast—to give one example, by 2050, the number of Alzheimer’s patients age 65 and older may nearly triple from 5 million to 13.8 million.
Huaxi Xu, Ph.D.
Jeanne and Gary Herberger Leadership Chair in Neuroscience Research
Rolf Bodmer, Ph.D.
Director and Professor, Development, Aging and Regeneration Program
Genetic diseases in children are rare, and often incurable. Research insights into the genes and environmental factors that play a role in the development of childhood diseases are leading to better ways to more accurately diagnose, treat and cure children with disease.
The Institute’s Cancer Center is one of only seven NCI-designated basic cancer research centers in the nation. We couple fundamental biological research with early translational studies to find new, innovative therapies that restore hope to cancer patients and their families.
Francesca Marassi, Ph.D.
Professor, Cancer Metabolism and Signaling Networks Program
Garth Powis, D. Phil.
Jeanne and Gary Herberger Leadership Chair in Cancer Research
The Center for Metabolic Origins of Disease studies common diseases that have reached pandemic scale including obesity, type 2 diabetes and cardiovascular complications. We have established an exciting environment that promotes multi-disciplinary discovery research toward breakthrough preventive and therapeutic strategies.
Laszlo Nagy, M.D., Ph.D.
Director and Adjunct Professor, Genomic Control of Metabolism Program
Masanobu Komatsu, Ph.D.
Adjunct Associate Professor, Cardiovascular Metabolism Program
The human immune system is made up of a network of cells, tissues and organs that fight off disease. It can also turn against the body causing autoimmune disorders, such as rheumatoid arthritis, lupus, Crohn’s disease and psoriasis. Increasingly, scientists are learning how to help the body’s immune system to combat cancer.
Adam Godzik, Ph.D.
Director and Professor, Bioinformatics and Structural Biology Program
Alex Strongin, Ph.D., D.Sci.
Professor, Bioinformatics and Structural Biology Program
Diseases associated with aging and development are already a leading cause of death and disability, and their prevalence is rising fast—to give one example, by 2050, the number of Alzheimer’s patients age 65 and older may nearly triple from 5 million to 13.8 million.
Rolf Bodmer, Ph.D.
Director and Professor, Development, Aging and Regeneration Program
Huaxi Xu, Ph.D.
Jeanne and Gary Herberger Leadership Chair in Neuroscience Research
Genetic diseases in children are rare, and often incurable. Research insights into the genes and environmental factors that play a role in the development of childhood diseases are leading to better ways to more accurately diagnose, treat and cure children with disease.
Drug Discovery and Technology
SBP has the talent and resources to accelerate the development of new therapeutics.
Through development and application of modern drug discovery technologies, SBP is uniquely positioned to make next-generation medicines.
The TMA identifies and advances lab discoveries with the greatest potential to address unmet clinical needs.
SBP innovates and maintains key technologies and expertise to facilitate research.
Through development and application of modern drug discovery technologies, SBP is uniquely positioned to make next-generation medicines.
The TMA identifies and advances lab discoveries with the greatest potential to address unmet clinical needs.
SBP innovates and maintains key technologies and expertise to facilitate research.
Today, there are 86 countries reporting Zika virus transmission through mosquitoes. SBP researchers have discovered that a drug to treat hepatitis C could treat the Zika virus.
Your support is vital to accelerating scientific discoveries to improve human health.